NASDAQ
No price data available for this timeframe.
Veraxa Biotech Holding AG is a clinical-stage biopharmaceutical company, formed via a merger with Voyager Acquisition Corp., focusing on developing next-generation cancer therapies such as antibody-drug conjugates (ADCs) and bispecific T-cell engagers. [64, 65]
Open
$1.76
Previous Close
$1.73
Day High
$2.41
Day Low
$1.76
52 Week High
$27.36
52 Week Low
$1.70